How long after positive fetal fibronectin did you deliver

The views expressed in community are solely the opinions of participants, and do not reflect those of What to Expect. Learn more about our guidelines
Just so you know, What to Expect may make commissions on shopping links on this page.

1. Maternal and Child Health Consortium. Confidential enquiries into stillbirths and deaths in infancy (CESDI): 6th annual report. London: Stationery Office; 1999. [Google Scholar]

2. Peters KD, Kochanek KD, Murphy SL. Deaths: final data for 1996. Natl Vital Stat Rep. 1998;47:1–100. [PubMed] [Google Scholar]

3. Department of Health (UK) NHS maternity statistics, England: 1989-90 to 1994-95. London: Stationery Office; 1997. www.doh.gov.uk/public/sb9728.htm (accessed 23 August 2001). [Google Scholar]

4. Stewart AL, Rifkin L, Amess PN, Kirkbride V, Townsend JP, Miller DH, et al. Brain structure and neurocognitive and behavioural function in adolescents who were born very preterm. Lancet. 1999;353:1653–1657. [PubMed] [Google Scholar]

5. Wolke D, Meyer R. Cognitive status, language attainment, and prereading skills of 6-year-old very preterm children and their peers: the Bavarian longitudinal study. Dev Med Child Neurol. 1999;41:94–109. [PubMed] [Google Scholar]

6. Crowley P. Prophylactic corticosteroids for preterm birth. Cochrane Database Syst Rev 2000;(2):CD000065. [PubMed]

7. Matsuura H, Takio K, Titani K, Greene T, Levery SB, Salyan ME, et al. The oncofetal structure of human fibronectin defined by monoclonal antibody FDC-6. Unique structural requirement for the antigenic specificity provided by a glycosylhexapeptide. J Biol Chem. 1988;263:3314–3322. [PubMed] [Google Scholar]

8. Lockwood CJ, Senyei AE, Dische MR, Casal D, Shah KD, Thung SN, et al. Fetal fibronectin in cervical and vaginal secretions as a predictor of preterm delivery. N Engl J Med. 1991;325:669–674. [PubMed] [Google Scholar]

9. Sadovsky Y, Friedman SA. Fetal fibronectin and preterm labor. N Engl J Med. 1992;326:709. [PubMed] [Google Scholar]

10. Shimoya K, Hashimoto K, Shimizu T, Saji F, Murata Y. Effect of sexual intercourse on fetal fibronectin concentration in cervicovaginal secretions. Am J Obstet Gynecol. 1998;179:255–256. [PubMed] [Google Scholar]

11. Brubaker DB, Ross MG, Marinoff D. The function of elevated plasma fibronectin in preeclampsia. Am J Obstet Gynecol. 1992;166:526–531. [PubMed] [Google Scholar]

12. Leitich H, Egarter C, Kaider A, Hohlagschwandtner M, Berghammer P, Husslein P. Cervicovaginal fetal fibronectin as a marker for preterm delivery: a meta-analysis. Am J Obstet Gynecol. 1999;180:1169–1176. [PubMed] [Google Scholar]

13. Revah A, Hannah ME, Sue-A Quan AK. Fetal fibronectin as a predictor of preterm birth: an overview. Am J Perinatol. 1998;15:613–621. [PubMed] [Google Scholar]

14. Faron G, Boulvain M, Irion O, Bernard PM, Fraser WD. Prediction of preterm delivery by fetal fibronectin: a meta-analysis. Obstet Gynecol. 1998;92:153–158. [PubMed] [Google Scholar]

15. Chien PFW, Khan KS, Ogston S, Owen P. The diagnostic accuracy of cervico-vaginal fetal fibronectin in predicting preterm delivery: an overview. Br J Obstet Gynaecol. 1997;104:436–444. [PubMed] [Google Scholar]

16. Song F, Sheldon T, Sutton AJ, Abrams KR, Jones DR. Methods for exploring heterogeneity in meta-analysis. Eval Health Prof. 2001;24:126–151. [PubMed] [Google Scholar]

17. Cochrane methods group on systematic review of screening and diagnostic tests: recommended methods, last updated on 6 June 1996. www.cochrane.org/cochrane/sadtdoc1.htm (accessed 7 April 2001).

18. Khan KS, Dinnes J, Kleijnen J. Systematic reviews to evaluate diagnostic tests. Eur J Obstet Gynecol Reprod Biol. 2001;95:6–11. [PubMed] [Google Scholar]

19. Honest H, Bachmann LM, Khan KS Electronic searching of the literature for systematic reviews of screening and diagnostic tests for preterm birth. Eur J Obstet Gynecol Reprod Biol (in press). [PubMed]

20. Ascarelli MH, Morrison JC. Use of fetal fibronectin in clinical practice. Obstet Gynecol Surv. 1997;52(suppl 4):S1–12. [PubMed] [Google Scholar]

21. Bartnicki J, Casal D, Kreaden US, Saling E, Vetter K. Fetal fibronectin in vaginal specimens predicts preterm delivery and very-low-birth-weight infants. Am J Obstet Gynecol. 1996;174:971–974. [PubMed] [Google Scholar]

22. Benattar C, Taieb J, Fernandez H, Lindendaum A, Frydman R, Ville Y. Rapid fetal fibronectin swab-test in preterm labor patients treated by betamimetics. Eur J Obstet Gynecol Reprod Biol. 1997;72:131–135. [PubMed] [Google Scholar]

23. Bittar RE, Yamasaki AA, Sasaki S, Zugaib M. Cervical fetal fibronectin in patients at increased risk for preterm delivery. Am J Obstet Gynecol. 1996;175:178–181. [PubMed] [Google Scholar]

24. Bon C, Roubille M, Mailliavin A, Pichot J. Fetal fibronectin detection for prediction of preterm delivery. Immuno Anal Biol Spec. 2000;15:96–108. [Google Scholar]

25. Chang TC, Chew TS, Pang M, Tan AC, Yeo GS. Cervicovaginal foetal fibronectin in the prediction of preterm labour in a low-risk population. Ann Acad Med Singapore. 1997;26:776–780. [PubMed] [Google Scholar]

26. Daskalakis GJ, Papantoniou NE, Koutsodimas NB, Papapanagiotou A, Antsaklis AJ. Fetal fibronectin as a predictor of preterm birth. J Obstet Gynaecol. 2000;20:347–353. [PubMed] [Google Scholar]

27. DiStefano L, Carta G, Di Paolantonio L, Palerno P, Moscarini M. Preterm delivery: Predictive value of cervico-vaginal fetal fibronectin. Clin Exp Obstet Gynecol. 1999;26:187–189. [PubMed] [Google Scholar]

28. Lijmer JG, Mol BW, Heisterkamp S, Bonsel GJ, Prins MH, van der Meulen JH, et al. Empirical evidence of design-related bias in studies of diagnostic tests. JAMA. 1999;282:1061–1066. [PubMed] [Google Scholar]

29. Khan KS, ter Riet G, Popay J, Nixon J, Kleijnen J. Study quality assessment (phase 5): conducting the review (stage 2). Undertaking systematic reviews of research on effectiveness. 1-20. York: University of York; 2001. (CRD Report No 4). [Google Scholar]

30. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–188. [PubMed] [Google Scholar]

31. Galbraith RF. A note on graphical presentation of estimated odds ratios from several clinical trials. Stat Med. 1988;7:889–894. [PubMed] [Google Scholar]

32. Greenland S. Quantitative methods in the review of epidemiologic literature. Epidemiol Rev. 1987;9:1–30. [PubMed] [Google Scholar]

33. Sutton AJ, Abrams KR, Jones DR, Sheldon TA, Song F. Systematic reviews of trials and other studies. Health Technol Assess. 1998;2:1–276. [PubMed] [Google Scholar]

34. Moses LE, Shapiro D, Littenberg B. Combining independent studies of a diagnostic test into a summary ROC curve: data analytic approaches and some additional considerations. Stat Med. 1993;12:1293–1316. [PubMed] [Google Scholar]

35. de Vries SO, Hunink MG, Polak JF. Summary receiver operating characteristic curves as a technique for meta-analysis of the diagnostic performance of duplex ultrasonography in peripheral arterial disease. Acad Radiol. 1996;3:361–369. [PubMed] [Google Scholar]

36. Jaeschke R, Guyatt G, Sackett DL. Users' guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? The evidence-based medicine working group. JAMA. 1994;271:703–707. [PubMed] [Google Scholar]

37. Rutter CM, Gatsonis CA. A hierarchical regression approach to meta-analysis of diagnostic test accuracy evaluations. Stat Med. 2001;20:2865–2884. [PubMed] [Google Scholar]

38. Song F, Khan KS, Dinnes J, Sutton A. Asymmetric funnel plots and publication bias in meta-analyses of diagnostic accuracy. Int J Epidemiol. 2002;31:88–95. [PubMed] [Google Scholar]

39. Goldenberg RL, Iams JD, Miodovnik M, Van Dorsten JP, Thurnau G, Bottoms S, et al. The preterm prediction study: risk factors in twin gestations. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Am J Obstet Gynecol. 1996;175:1047–1053. [PubMed] [Google Scholar]

40. Morrison JC, Naef RW, 3rd, Botti JJ, Katz M, Belluomini JM, McLaughlin BN. Prediction of spontaneous preterm birth by fetal fibronectin and uterine activity. Obstet Gynecol. 1996;87:649–655. [PubMed] [Google Scholar]

41. Tolino A, Ronsini S, Zullo F, Pellicano M, Regine V, Nappi C. Fetal fibronectin as a screening test for premature delivery in multiple pregnancies. Int J Gynaecol Obstet. 1996;52:3–7. [PubMed] [Google Scholar]

42. Faron G, Boulvain M, Lescrainier JP, Vokaer A. A single cervical fetal fibronectin screening test in a population at low risk for preterm delivery: an improvement on clinical indicators? Br J Obstet Gynaecol. 1997;104:697–701. [PubMed] [Google Scholar]

43. Hellemans P, Gerris J, Verdonk P. Fetal fibronectin detection for prediction of preterm birth in low risk women. Br J Obstet Gynaecol. 1995;102:207–212. [PubMed] [Google Scholar]

44. Crane JM, Armson BA, Dodds L, Feinberg RF, Kennedy W, Kirkland SA. Risk scoring, fetal fibronectin, and bacterial vaginosis to predict preterm delivery. Obstet Gynecol. 1999;93:517–522. [PubMed] [Google Scholar]

45. Heath VC, Daskalakis G, Zagaliki A, Carvalho M, Nicolaides KH. Cervicovaginal fibronectin and cervical length at 23 weeks of gestation: relative risk of early preterm delivery. Br J Obstet Gynaecol. 2000;107:1276–1281. [PubMed] [Google Scholar]

46. Coleman MA, McCowan LM, Pattison NS, Mitchell M. Fetal fibronectin detection in preterm labor: evaluation of a prototype bedside dipstick technique and cervical assessment. Am J Obstet Gynecol. 1998;179:1553–1558. [PubMed] [Google Scholar]

47. Coleman MA, Keelan JA, McCowan LM, Townend KM, Mitchell MD. Predicting preterm delivery: comparison of cervicovaginal interleukin (IL)-1beta, IL-6 and IL-8 with fetal fibronectin and cervical dilatation. Eur J Obstet Gynecol Reprod Biol. 2001;95:154–158. [PubMed] [Google Scholar]

48. Grandi C, Perego M, Briozzo G, Cassini A. Fibronectina fetal (fFN) en secrecion cervical como predictor del parto prematuro. Rev Hosp Mat Inf Ramon Sarda. 1996;15:127–136. [Google Scholar]

49. Morrison JC, Allbert JR, McLaughlin BN, Whitworth NS, Roberts WE, Martin RW. Oncofetal fibronectin in patients with false labor as a predictor of preterm delivery. Am J Obstet Gynecol. 1993;168:538–542. [PubMed] [Google Scholar]

50. Senden IPM, Owen P. Comparison of cervical assessment, fetal fibronectin and fetal breathing in the diagnosis of preterm labour. Clin Exp Obstet Gynecol. 1996;23:5–9. [PubMed] [Google Scholar]

51. LaShay N, Gilson G, Joffe G, Qualls C, Curet L. Will cervicovaginal interleukin-6 combined with fetal fibronectin testing improve the prediction of preterm delivery? J Matern Fetal Med. 2000;9:336–341. [PubMed] [Google Scholar]

52. Luo L, Lu Q, Wei F. [Fetal fibronectin and preterm birth] Zhonghua Fu Chan Ke Za Zhi. 1997;32:25–26. [PubMed] [Google Scholar]

53. Gebhardt S, Odendaal HJ. Fetal fibronectin in vaginal secretions—a predictor of preterm delivery? [letter] S Afr Med J. 1995;85:188. [PubMed] [Google Scholar]

54. Hampl M, Friese K, Hofmann I, Melchert F. [Quantitative determination of fetal fibronectin in cervical smears: a new marker for evaluating the risk in premature labour.] Geburtshilfe Frauenheilkd. 1994;54:685–690. [PubMed] [Google Scholar]

55. Khan KS, Chien PF. Seizure prophylaxis in hypertensive pregnancies: a framework for making clinical decisions. Br J Obstet Gynaecol. 1997;104:1173–1179. [PubMed] [Google Scholar]

56. Usher RH, Allen AC, McLean FH. Risk of respiratory distress syndrome related to gestational age, route of delivery, and maternal diabetes. Am J Obstet Gynecol. 1971;111:826–832. [PubMed] [Google Scholar]

57. Sinclair JC. Meta-analysis of randomized controlled trials of antenatal corticosteroid for the prevention of respiratory distress syndrome: discussion. Am J Obstet Gynecol. 1995;173:335–344. [PubMed] [Google Scholar]

58. Giles W, Bisits A, Knox M, Madsen G, Smith R. The effect of fetal fibronectin testing on admissions to a tertiary maternal-fetal medicine unit and cost savings. Am J Obstet Gynecol. 2000;182:439–442. [PubMed] [Google Scholar]

59. Lopez RL, Francis JA, Garite TJ, Dubyak JM. Fetal fibronectin detection as a predictor of preterm birth in actual clinical practice. Am J Obstet Gynecol. 2000;182:1103–1106. [PubMed] [Google Scholar]

60. Iams JD, Casal D, McGregor JA, Goodwin TM, Kreaden US, Lowensohn R, et al. Fetal fibronectin improves the accuracy of diagnosis of preterm labor. Am J Obstet Gynecol. 1995;173:141–145. [PubMed] [Google Scholar]

61. Leeson SC, Maresh MJA, Martindale EA, Mahmood T, Muotune A, Hawkes N, et al. Detection of fetal fibronectin as a predictor of preterm delivery in high risk asymptomatic pregnancies. Br J Obstet Gynaecol. 1996;103:48–53. [PubMed] [Google Scholar]

62. Lukes AS, Thorp JM, Jr, Eueker B, Pahel-Short L. Predictors of positivity for fetal fibronectin in patients with symptoms of preterm labor. Am J Obstet Gynecol. 1997;176:639–641. [PubMed] [Google Scholar]

63. Malak TM, Sizmur F, Bell SC, Taylor DJ. Fetal fibronectin in cervicovaginal secretions as a predictor of preterm birth. Br J Obstet Gynaecol. 1996;103:648–653. [PubMed] [Google Scholar]

64. McKenna DS, Chung K, Iams JD. Effect of digital cervical examination on the expression of fetal fibronectin. J Reprod Med. 1999;44:796–800. [PubMed] [Google Scholar]

65. Peaceman AM, Andrews WW, Thorp JM, Cliver SP, Lukes A, Iams JD, et al. Fetal fibronectin as a predictor of preterm birth in patients with symptoms: a multicenter trial. Am J Obstet Gynecol. 1997;177:13–18. [PubMed] [Google Scholar]

66. Nageotte MP, Casal D, Senyei AE. Fetal fibronectin in patients at increased risk for premature birth. Am J Obstet Gynecol. 1994;170:20–25. [PubMed] [Google Scholar]

67. Oliveira T, de Souza E, Mariani-Neto C, Camano L. Fetal fibronectin as a predictor of preterm delivery in twin gestations. Int J Gynecol Obstet. 1998;62:135–139. [PubMed] [Google Scholar]

68. Oliveira TA, Carvalho CM, de Souza E, Mariani-Neto C, Camano L. Detection of fetal fibronectin in twin pregnancies in relation to gestational age. Sao Paulo Med J. 1999;117:121–124. [PubMed] [Google Scholar]

69. Krems J, McGregor J, Hastings C, Hanson J. Fetal fibronectin in cervical secretions: an aid for predicting delivery in women at high risk for preterm delivery. Am J Obstet Gynecol. 1995;172:406. [Google Scholar]

70. Nageotte MP, Hollenbach KA, Vanderwahl BA, Hutch KM. Oncofetal fibronectin in patients at increased risk for preterm delivery. Am J Obstet Gynecol. 1992;166:274. [Google Scholar]

71. Garcia Alonso A, Ayala Mendez JA, Izquierdo Puente JC, Jimenez Solis G, Sanchez Martinez M. Presencia de fibronectina fetal en secrecion cervico-vaginal como predictor de parto pretermino [Presence of fetal fibronectin in cervico-vaginal secretion as predictor of premature labor] Ginecol Obstet Mex. 1999;67:23–28. [PubMed] [Google Scholar]

72. Greenhagen JB, Van Wagoner J, Dudley D, Hunter C, Mitchell M, Logsdon V, et al. Value of fetal fibronectin as a predictor of preterm delivery for a low-risk population. Am J Obstet Gynecol. 1996;175:1054–1056. [PubMed] [Google Scholar]

73. Zamora Scorza FC, Fernandez G, de Lamanna MP, Perez MC, Maris CA. Valor de la fibronectina fetal en secreciones cervicales en la prediccion del parto pretermino en pacientes con membranas integras. Rev Obstet Ginecol Venez. 2000;60:15–22. [Google Scholar]

74. Arinami Y, Hasegawa I, Takakuwa K, Tanaka K. Prediction of preterm delivery by combined use of simple clinical tests. J Matern Fetal Med. 1999;8:70–73. [PubMed] [Google Scholar]

75. Goldenberg RL, Mercer BM, Meis PJ, Copper RL, Das A, McNellis D. The preterm prediction study: fetal fibronectin testing and spontaneous preterm birth. Obstet Gynecol. 1996;87:643–648. [PubMed] [Google Scholar]

76. Goldenberg RL, Mercer BM, Iams JD, Moawad AH, Meis PJ, Das A, et al. The preterm prediction study: patterns of cervicovaginal fetal fibronectin as predictors of spontaneous preterm delivery. Am J Obstet Gynecol. 1997;177:8–12. [PubMed] [Google Scholar]

77. Goldenberg RL, Klebanoff M, Carey JC, MacPherson C, Leveno KJ, Moawad AH, et al. Vaginal fetal fibronectin measurements from 8 to 22 weeks' gestation and subsequent spontaneous preterm birth. Am J Obstet Gynecol. 2000;183:469–475. [PubMed] [Google Scholar]

78. Hux CH, Trolice MP, Kadar N. The value of a single fetal fibronectin assay as a screen for preterm labor and delivery. J Matern Fetal Med. 1995;4:100–104. [Google Scholar]

79. Inglis SR, Jeremias J, Kuno K, Lescale K, Peeper Q, Chervenak FA, et al. Detection of tumor necrosis factor-alpha , interleukin-6, and fetal fibronectin in the lower genital tract during pregnancy: relation to outcome. Am J Obstet Gynecol. 1994;171:5–10. [PubMed] [Google Scholar]

80. Lockwood CJ, Wein R, Lapinski R, Casal D, Berkowitz G, Alvarez M, et al. The presence of cervical and vaginal fetal fibronectin predicts preterm delivery in an inner-city obstetric population. Am J Obstet Gynecol. 1993;169:798–804. [PubMed] [Google Scholar]

81. Vercoustre L, Sotter S, Bouige D, Walch R. Place de la fibronectine foetale dans la prediction du travail. Resultats et commentatires a propos de 206 prelevements. [Fibronectin as a predictor of labor, results and discussion about 206 samples] Gynecol Obstet. 1996;4:23–32. [Google Scholar]

82. Malagrida L, Rozenberg P, Simon G, Giudicelli Y. Detection of fetal fibronectin in cervical and secretions to predict preterm birth. ImmunoAnal Biol Spec. 1995;10:355–359. [Google Scholar]

83. Surbek D, Bosiger H, Pavic N, Huber P, Almendral AC, Holzgreve W. [Fetal fibronectin as a predictor of preterm birth in patients at increased risk] Z Geburtshilfe Neonatol. 1997;201:15–20. [PubMed] [Google Scholar]

84. Roubille M, Mailliavin A, Biguet-Vernier B, Bon C, Golfier F, Pichot JC. Interet de la recherche de la fibronectine foetale dans le depitage du risque d'accouchement premature [Fetal fibronectin as predictor of preterm birth] Ann Biol Clin Paris. 1999;57:93–97. [PubMed] [Google Scholar]

85. Calda P, Cibula D, Doudova D, Binder T, Peterka T, Zizka Z, et al. Fetalni fibronektin v cerviko-vaginalnim sekretu--indikator pocinajiciho predcasneho porodu metodou membranove imunoeseje [Fetal fibronectin in cervico-vaginal secretions—an indicator of incipient premature labor using a membrane immunoassay] Ceska Gynekol. 1995;60:293–295. [PubMed] [Google Scholar]

86. Burrus DR, Ernest JM, Veille JC. Fetal fibronectin, interleukin-6, and C-reactive protein are useful in establishing prognostic subcategories of idiopathic preterm labor. Am J Obstet Gynecol. 1995;173:1258–1262. [PubMed] [Google Scholar]

87. Goffeng AR, Holst E, Milsom I, Lindstedt G, Lundberg PA, Andersch B. Fetal fibronectin and microorganisms in vaginal fluid of women with complicated pregnancies. Acta Obstet Gynecol Scand. 1997;76:521–527. [PubMed] [Google Scholar]

88. Irion O, Matute J, Bischof P. [Prediction of prematurity with oncofoetal fibronectin. Prospective cohort study] J Gynecol Obstet Biol Reprod Paris. 1995;24:624–629. [PubMed] [Google Scholar]

89. Langer B, Boudier E, Schlaeder G. Cervico-vaginal fetal fibronectin: predictive value during false labor. Acta Obstet Gynecol Scand. 1997;76:218–221. [PubMed] [Google Scholar]

90. Parker J, Bell R, Brennecke S. Fetal fibronectin in the cervicovaginal fluid of women with threatened preterm labour as a predictor of delivery before 34 weeks' gestation. Aust N Z J Obstet Gynaecol. 1995;35:257–261. [PubMed] [Google Scholar]

91. Rizzo G, Capponi A, Arduini D, Lorido C, Romanini C. The value of fetal fibronectin in cervical and vaginal secretions and of ultrasonographic examination of the uterine cervix in predicting premature delivery for patients with preterm labor and intact membranes. Am J Obstet Gynecol. 1996;175:1146–1151. [PubMed] [Google Scholar]

92. Rizzo G, Capponi A, Vlachopoulou A, Angelini E, Grassi C, Romanini C. The diagnostic value of interleukin-8 and fetal fibronectin concentrations in cervical secretions in patients with preterm labor and intact membranes. J Perinat Med. 1997;25:461–468. [PubMed] [Google Scholar]

93. Rozenberg P, Goffinet F, Malagrida L, Giudicelli Y, Perdu M, Houssin I, et al. Evaluating the risk of preterm delivery: a comparison of fetal fibronectin and transvaginal ultrasonographic measurement of cervical length. Am J Obstet Gynecol. 1997;176:196–199. [PubMed] [Google Scholar]

94. Wennerholm UB, Holm B, Mattsby-Baltzer I, Nielsen T, Platz-Christensen J, Sundell G, et al. Fetal fibronectin, endotoxin, bacterial vaginosis and cervical length as predictors of preterm birth and neonatal morbidity in twin pregnancies. Br J Obstet Gynaecol. 1997;104:1398–1404. [PubMed] [Google Scholar]

95. Chuileannain FN, Bell R, Brennecke S. Cervicovaginal fetal fibronectin testing in threatened preterm labour—translating research findings into clinical practice. Aust N Z J Obstet Gynaecol. 1998;38:399–402. [PubMed] [Google Scholar]

96. Vetr M, Kudela M, Prasilova J. Fetal fibronectin in patients at increased risk for premature birth. Acta Univ Palacki Olomuc Fac Med. 1996;140:55–57. [PubMed] [Google Scholar]

97. Cox S, Little B, Dax J, Leveno K. Fetal fibronectin and preterm delivery. Am J Obstet Gynecol. 1996;174:306. [Google Scholar]

98. Mansouri A, Tadjerouni A, El Rabiey G, Baube S, Garnier G, Tribalat S. [Is fetal fibronectin a valid test predictive of preterm delivery?] Contracept Fertil Sex. 1997;25:380–384. [PubMed] [Google Scholar]

99. Patricot MC, Pallant DA, Mathian B. Fetal fibronectin for prediction of preterm delivery. ImmunoAnal Biol Spec. 1997;12:81–84. [Google Scholar]

What happens after a positive fetal fibronectin test?

How accurate is a fetal fibronectin test?

How Long Can preterm labor be delayed?

How many weeks can you do a fFN?